![Thomas Uhlin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Uhlin
Plus aucun poste en cours
Health Technology
Profil
Thomas Uhlin was the Chief Executive Officer of Aprea Therapeutics AB and held Principal positions at Orexo AB and Doxa AB.
Anciens postes connus de Thomas Uhlin
| Sociétés | Poste | Fin |
|---|---|---|
| OREXO AB | Corporate Officer/Principal | - |
| DOXA AB | Corporate Officer/Principal | - |
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops novel anticancer compounds | President | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Orexo AB
 Orexo AB Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products | Health Technology |
Doxa AB
 Doxa AB Medical SpecialtiesHealth Technology Develops, manufactures, and commercializes bio ceramic dental products | Health Technology |
Aprea Therapeutics AB
Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops novel anticancer compounds | Health Technology |
